RxSight, Inc. Earnings Per Share (Diluted)
RxSight, Inc. (RXST) reported Earnings Per Share (Diluted) of -$0.29 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- RxSight, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.29.
- RxSight, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.38.
- RxSight, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $0.72, a 35.73% increase year-over-year.
- RxSight, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.24.
- RxSight, Inc. earnings per share, diluted for fiscal 2025 was -$0.95.
- RxSight, Inc. earnings per share, diluted for fiscal 2024 was -$0.71.
- RxSight, Inc. earnings per share, diluted for fiscal 2023 was -$1.41.
- RxSight, Inc. earnings per share, diluted for fiscal 2022 was -$2.41.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.29 10-Q · filed 2026-08-05 | -$0.68 10-Q · filed 2026-08-05 | $0.04 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | -$0.38 10-Q · filed 2026-05-06 | $0.34 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.10 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $0.72 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.49 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.20 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.95 10-K · filed 2026-02-25 |
| 2025-09-30 | -$0.24 10-Q · filed 2025-11-05 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.73 10-Q · filed 2025-11-05 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$0.29 10-Q · filed 2026-08-05 | -$0.49 10-Q · filed 2026-08-05 | $0.04 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$0.20 10-Q · filed 2026-05-06 | $0.33 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.17 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.02 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2024-12-31 | $0.53 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.38 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.23 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.71 10-K · filed 2026-02-25 |
| 2024-09-30 | -$0.16 10-Q · filed 2025-11-05 | -$0.32 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.56 10-Q · filed 2025-11-05 | $0.47 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-06-30 | -$0.16 10-Q · filed 2025-08-07 | -$0.40 10-Q · filed 2025-08-07 | $0.65 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.32 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-03-31 | -$0.25 10-Q · filed 2025-05-07 | $0.83 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.50 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.12 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2023-12-31 | $1.10 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.75 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.37 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.41 10-K · filed 2026-02-25 |
| 2023-09-30 | -$0.35 10-Q · filed 2024-11-07 | -$0.75 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.16 10-Q · filed 2024-11-07 | $0.36 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2023-06-30 | -$0.40 10-Q · filed 2024-08-05 | -$0.82 10-Q · filed 2024-08-05 | $0.77 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.24 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2023-03-31 | -$0.42 10-Q · filed 2024-05-06 | $1.27 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.73 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.15 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2022-12-31 | $1.83 derived: net income ÷ weighted average shares · filed 2026-04-28 | $1.23 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.63 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$2.41 10-K · filed 2025-02-25 |
| 2022-09-30 | -$0.61 10-Q · filed 2023-11-09 | -$1.22 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.86 10-Q · filed 2023-11-09 | -$2.43 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.61 10-Q · filed 2023-08-07 | -$1.25 10-Q · filed 2023-08-07 | -$1.82 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.48 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.64 10-Q · filed 2023-05-09 | -$1.21 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.87 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$3.06 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.23 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$2.49 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$3.57 10-K · filed 2023-03-06 |
| 2021-09-30 | -$0.68 10-Q · filed 2022-11-07 | -$2.28 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$3.66 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$3.53 10-Q · filed 2022-08-08 | -$5.23 10-Q · filed 2022-08-08 | ||
| 2020-12-31 | $1.19 derived: net income ÷ weighted average shares · filed 2022-03-08 | $5.15 derived: net income ÷ weighted average shares · filed 2022-03-08 | $5.98 derived: net income ÷ weighted average shares · filed 2022-03-08 | $0.15 10-K · filed 2022-03-08 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-09 | $0.00 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |